NCT01599988已完成2 期
A Randomised, Double-blinded Study to Compare Milk Protein Isolate (MPI)With Caseinate in Terms of Protein Utilization in Healthy Elderly Subjects
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Protein utilization
研究概览
简要总结
The Clinical Research Ethics Committee, Cork comprises of faculty representatives, external representatives, legal representatives and appropriate individuals and ex-officio administrative members with needed expertise. Ethics Committee members, including the Chair, are appointed by the Head of College, University College Cork, Medical School.
The Ethics Committee meets once a month.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 65 Years 至 75 Years（Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •To be considered eligible for enrolment into the study, subjects must;
- •Be able to give written informed consent.
- •Be between 65 and 75 years of age.
- •Be in generally good health as determined by the investigator.
- •Have no evidence of gastrointestinal disease or of a functional gastrointestinal disorder as determined by the Bowel Disease Questionnaire.
- •Have a stable body weight over the past 3-months.
- •Have a Body Mass Index (BMI) greater than 22, for males and 20 for females and less than
- •Have a satisfactory nutritional status.
排除标准
- •Subjects will be excluded from the study if they meet any of the below criteria;
- •Are less than 65 and greater than 75 years of age.
- •Have evidence of gastrointestinal disease or other functional gastrointestinal disorder as determined by the Bowel Disease Questionnaire.
- •Have a significant acute or chronic coexisting illness (cardiovascular, gastrointestinal, endocrinological, immunological, metabolic or any condition which contraindicates, in the investigators judgement, entry to the study).
- •Having a condition or taking a medication that the investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results; to include anti-inflammatory drugs, corticosteroids, laxatives, enemas, antibiotics (within 1 month), anti-coagulants, and over-the counter non-steroidal analgesics. Subjects should have a wash-out period of two-weeks.
- •Be a smoker.
- •Consume more than the recommended alcohol guidelines i.e. 3-4 alcohol units a day for a man and for a woman 2-3 units a day.
- •Suffer from psychiatric disease
- •Prior gastrointestinal surgery (apart from appendicectomy and hernia repair) or recent unexplained bleeding.
- •Have dietary habits (slimming or vegetarian diet) which could interfere with the assessment of the study product.
- •Individuals who, in the opinion of the investigator, are considered to be poor attendees or unlikely for any reason to be able to comply with the trial.
- •Subjects may not be receiving treatment involving experimental drugs.
- •If the subject has been in a recent experimental trial, these must have been completed not less than 30 days prior to this study.
- •Have a malignant disease or any concomitant end-stage organ disease
结局指标
主要结局
Protein utilization
时间窗: Up to 8 hours
次要结局
- Blood glucose concentrations(Up to 8 hours)
- Plasma insulin levels(Up to 8 hours)
- Serum triglycerides(Up to 8 hours)
研究者
Andrea Doolan
Human Studies Manager
University College Cork
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Effect of Dietary Cholesterol on Plasma LipidsDietary ModificationNutritional and Metabolic DiseaseNCT03698929Physicians Committee for Responsible Medicine9
已完成
1 期
A Randomized, Double-Blind, Placebo-Controlled Study of Oral Milk Immunotherapy for Cow's Milk AllergyMilk HypersensitivityNCT00465569Johns Hopkins University20
Unknown
不适用
CMI-168 on Cognitive Function in Healthy Middle-aged Men and WomenCognitive ChangeNCT03612752Cerebos Pacific Limited90
已完成
4 期
Pregabalin and Post-thoracotomy PainChronic PainNCT00663962Queen's University15
已完成
3 期
Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in AdultsCovid19NCT04617483Sinovac Research and Development Co., Ltd.1,040